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Activated monocytes produce a variety of cytokines that are involved in inflam-
mation, such as IL-1, TNF, chemotactic factors, transforming growth factor R,
platelet-derived growth factor, and IFN-a and -Q (1). Chemotactic factors released
at foci of injury or bacterial invasion are thought to mediate directed migration of
leukocytes into inflammatory sites. Since the leukocyte composition of the inflam-
matory infiltrate depends on the temporal stage ofthe lesion (2) and the nature of
the stimulus (3), it follows that some chemoattractants should be specific for a given
type ofleukocyte. We recently showed that LPS-stimulated monocytes produce a
chemotactic factor that attracts neutrophils, but not monocytes (4). We purifiedthis
factor to homogeneity and described the N1-12-terminal sequence of the first 42
amino acids (5). We now report molecular cloningand sequencing ofthefull-length
cDNA for this monocyte-derived neutrophil chemotactic factor (MDNCF)' and the
deduced amino acid sequence of the entire molecule. Specific cDNA probes also
enabled us to test the capacity ofa numberofcytokines to induce MDNCF mRNA
expression in human PBMC. The stimulation of MDNCF mRNA expression by
IL-1 and TNF suggests that the local pro-inflammatory action of these cytokines
may be mediated by induction of chemotactic factor secretion.
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Materials and Methods
cDNA Cloning ofMDNCF and Nucleotide Sequence.
￿
Normal human PBMC were first frac-
tionated by Ficoll-Hypaque and plastic adherent cells (> 90% nonspecific esterase-positive
monocytes), were cultured in RPMI-1640 medium supplemented with 1% FCSand 10 ug/ml
LPS (Serotype 055:1155; Difco Laboratories Inc., Detroit, MI) for 6 h at 37°C . Total RNA
T Yoshimurawas supportedby aJapanese Overseas Cancer Fellowship of the Foundation forPromo-
tion of Cancer Research. Address correspondence to K. Matsushima, Laboratory of Molecular Im-
munoregulation, National Cancer Institute, NIH, Bldg. 560, Room 31-19, Frederick, MD 21701-1013.
' Abbreviation used in this paper: MDNCF, monocyte-derived neutrophil chemotactic factor.
18831884
￿
NEUTROPHIL CHEMOTACTIC FACTOR cDNA CLONING
was isolated by guanidine-isothiocyanate extraction and polyadenylated MRNA was purified
by oligo-dT-cellulose chromatography. Double-stranded cDNA was synthesized from
poly(A)' RNA by the Amersham Corp., (Arlington Heights, IL) cDNA synthesis system,
which is based on the method ofGubler and Hoffman (6). After treatment with Eco RI meth-
ylase and T4 DNA polymerase, the double-stranded DNA was fractioned by gel filtration,
inserted into the Eco RI site of X gt10 with Eco RI linkers, and packaged in vitro by means
of Gigapack (Stratagene, San Diego, CA). 5 x 105 plaques were screened with mixtures of
32P-labeled oligonucleotide probes (2 x 106 cpm/ml) by hybridizing nitrocellulose filters at
50°C and then lowering the temperature to 37°C. After hybridization, the filters were washed
with 6 x SSC for 15 min at 25'C three times and once for 1 min at 37'C. The filters were
exposed at - 80°C overnight to Kodak X-Omat x-ray film. Positive clones were recloned in
a similar way and one strongly positive clone was expanded in Escherichia coli Hfl-C600 (termed
r-MDNCF 2-1). The cDNA in r-MDNCF 2-1 was digested with Eco RI; 1.2-kb and 0.5-kb
cDNA fragments were obtained. Southern blotting analysis of these MMDNCF cDNA re-
striction fragments using 32P-labled oligonucleotide probes indicated that the 0.5-kb fragment
hybridized to the oligoprobes. Each cDNA fragment was subcloned into pUC19 plasmids
and expanded in DH-5 host cells. DNA sequence analysis was performed by the dideoxy
method of Sanger et al. (7) and the chemical cleavage method of Maxam and Gilbert (8).
Construction ofpSP18-14 andIn Vitro Transcription and Translation.
￿
pSP18 (Bethesda Research
Laboratories, Gaithersburg, MD) (0.75 wg) was digested with 5 U of Pst I and 5 U of Eco
RI at 37°C for 90 min. The 0.3-kb Pst I-Eco RI fragment of MDNCF 2-1 was ligated into
the digested pSP18 plasmid by the method of Maniatis et al. (9), and then transferred into
JM 105-competent cells. Resultant colonies were confirmed for orientation of the 0.3-kb Pst
I-Eco RI fragment by restriction endonuclease mapping. One isolate (termed pSP18-14) was
linearized with Eco RI, and then purified DNA (1 ug) was used as a template to synthesize
RNA transcripts by SP6 RNA polymerase according to the method of Noma et al. (10). The
size and yield of the RNA was determined by agarose gel electrophoresis to be 0.3 kb and
0.3 ug, respectively. The transcript was translated into protein in a rabbit reticulocyte lysate
in the presence of 0.1 nmol of [3H]leucine (120 Ci/mmol) at 30°C for 60 min according to
the manufacturer's recommendation (Bethesda Research Laboratories).
Northern Blotting Analysis.
￿
25-50 ng ofthe 0.3-kb Pst I-Eco RI fragment ofMDNCF cDNA
and chicken a-actin cDNA (Bethesda Research Laboratories) were labeled with deoxycyti-
dine 5'-a-[32p]triphosphate triethylammonium salt (3,000 Ci/mmol) by a random primer
DNA labeling kit (Boehringer Mannheim Biochemicals, Indianapolis, IN). Unincorporated
a-[32p]dCTP was removed by nucleic acid chromatography system (NACS) column chro-
matography (Bethesda Research Laboratories). The specific activity of the resulting DNA
was N5 x 108 cpm/wg. For Northern blotting analyses, whole human PBMC were stimu-
lated with 10 wg/ml LPS, 100 U/ml human rIL-la (endotoxin-free, purified; Dainippon Phar-
macuetical Co. Ltd., Osaka, Japan), 100 U/ml human rTNF (endotoxin-free, puri-
fied; Dainippon Pharmaceutical Co. Ltd.), 100 U/ml human rIFN-a (endotoxin-free, purified,
Hoffmann-La Roche, Inc., Nutley, NJ), 100 U/ml human rIFN-y (endotoxin-free, puri-
fied, Genentech, Inc., South San Francisco, CA) or 100 U/ml human rIL-2 (endotoxin-free,
purified; Hoffman-La Roche). Total RNA was isolated by guanidine-isothiocyanate extrac-
tion followed by cesium chloride density gradient centrifugation. Purified total RNA was elec-
trophoresed in a 1% agarose gel containing 6.5% formaldehyde for ti5 h at 60 V, and then
transferred to a nylon membrane. After transfer, the membrane was baked at 80'C for 2 h
under vacuum and prehybridized at 42°C overnight. The prehybridization solution contained
5 x SSC, 50% formamide, 0.1% Ficoll, 0.10 1o SDS, 1017o dextran sulfate, 50 wg/ml yeast tRNA,
and 100 ug/ml salmon sperm DNA in 50 mM sodium phosphate buffer, pH 6.5. Hybridiza-
tion was performed at 42°C overnight in the above mixture supplemented with 32P-labeled
cDNA probe (2-5 x 108 cpm/wg) at 106 cpm/ml. After hybridization, the membrane was
washed twice with 0.1 x SSC, 1% SDS at room temperature, then washed twice with 0.1
x SSC, 1% SDS at 60°C. The membrane was exposed to x-ray film with an intensifying
screen at -80'C .
Immunoprecipitation ofMDNCF-expressed in Cellfree System.
￿
Rabbit polyclonal antibodies toMATSUSHIMA ET AL.
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MDNCF were prepared by immunizing a rabbit with purified homogeneous MDNCF (5).
Immunoprecipitation ofradiolabeled MDNCFin the reticulocyte-lysate with polyclonal anti-
MDNCFcoupled to protein ASepharose 4B was carried out at 4°C afterremoval by absorp-
tion ofnonspecifically bound molecules with normal rabbit IgG coupled to protein A-Sepharose.
HPLC Gel Filtration.
￿
HPLC gel filtration of culture supernatants from PBMC was per-
formed at room temperature on a 7 .5 x 600 mm TSK 3000 column equilibrated with Dul-
becco's PBS, pH 7 .4 1-ml fractions were collected at flow rate of 1 ml/min. The column was
calibratedwith BSA (mol wt 67,000), OVA (mol wt 43,000), and cytochrome c (mol wt 12,500).
Neutrophil chemotactic activity was measured in a multiwell chemotaxis chamber as previ-
ously described (11).
Results
cDNA CloningforMDNCF
￿
The computer-assisted sequence homology test (Word
Search by University ofWisconsin Genetic Computer Group, Madison, WI) of the
N142-terminal sequence of MDNCF derived from LPS-stimulated PBMC showed
that MDNCF has a unique protein sequence (Fig. 1 A). Therefore, cDNA cloning
of MDNCF was initiated and oligo nucleotideprobes (Fig. 1 B) based on the MDNCF
amino acid sequence were synthesized for the screening ofa cDNA library. The cDNA
library was constructed by insertion ofcDNA synthesized from normal human mono-
cyte polyadenylated mRNA obtained after stimulation of the monocytes with 10
gg/ml LPS for 6 h, into the Eco RI site of the phage vector Xgt10. 5 x 105 individual
plaques were screened for hybridization with "P-labeled oligonucleotide probes. Al-
though 13 putative positive clones were obtained in the first screening, only one clone
was positive in the second screening (termed r-MDNCF 2-1). The phage DNA in
r-MDNCF 2-1 was digested by Eco RI and 1 .2- and 0.5-kb cDNA fragments were
obtained from agarose gel electrophoresis. Each Eco RI DNA fragment was sub-
cloned into the pUC19 plasmid (termed p-MDNCF 2-1, 1 .2, and p-MDNCF 2-1,
0.5) . The cDNA was sequenced by the dideoxy method of Sanger et al. (7) and the
chemical cleavage method of Maxam and Gilbert (8). Fig. 1 C shows restriction en-
donuclease maps ofthe cDNA insert ofMDNCF 2-1 and the strategy for the nucleotide
sequencing. Fig. 1 D shows the complete nucleotide and deduced amino acid se-
quence of MDNCF There is a 101-base 5' untranslated region, a 297-base coding
region, and a long 1 .2-kb 3' untranslated region. The initial AUG codon begins an
open reading frame that encodes a 99-amino acid polypeptide. No otherAUG-initiated
open reading frame of sufficient length to code of MDNCF was found in the cDNA
sequence. The 3' untranslated region contains a nucleotide sequence TATTTATT
beginning 609 bases from the 5' region that is identical to a conserved sequence present
in the mRNA of many inflammatory mediators such as TNF mRNA (12). The
N142-terminal. end of the deduced amino acid sequence is highly hydrophobic and
this N142-terminal hydrophobic region is consistent with a typical signal peptide
sequence (13). Based on the NH2-terminal amino acid sequence of purified
MDNCF, the mature form ofthe protein starts with serine at residue 28. The deduced
amino acid sequence shows complete identity with the first 42 residues of purified
MDNCF as determined by the Edman degradation method (5). The reading frame
terminates with serine at residue 99, which would make a deduced mature protein
of 72 amino acids and a calculated molecular mass of8 kD. Purified natural MDNCF
fits this deduction, since the molecular mass determined by SDS-PAGE was -8 kD,
and the amino acid composition corresponds to that of the deduced protein. The1886
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FIGURE 1 .
￿
Nucleotide sequence anddeduced amino acid sequence ofMDNCF. (A)Amino acid
sequence of natural MDNCFpurified from conditioned medium of LPS-stimulated PBMC (5).
(B)Oligoprobes used for screening of the cDNA library. (G Restriction endonuclease cleavage
maps of the cDNA insert of pMDNCF 2-1. Solid arrows indicates the regions determined by
dideoxy method. Broken arrows indicatesthe regions determined by chemical reaction method.
(D) Nucleotide sequence and deduced aminoacid sequence oftheplasmid pMDNCF 2-1 cDNA
insert. The hydrophobic core of the predicted signal sequence is underlined with a broken line.
The amino acid sequence from which oligonucleotide probes were synthesized for the cDNA
cloning is underlined with a solid line. The arrow indicates the site forthe NH2 terminal of the
mature form of MDNCF. These sequence data have been submitted to the EMBL/GenBank
Data Libraries under accession number Y00787.
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FIGURE 2 .
￿
Translation ofMDNCFmRNA in reticulocyte lysate system .
deducedamino acid sequence ofMDNCFcontains no N-glycosylation site (asparagine-
X-threonine or asparagine-X-serine) .
Expression ofMDNCFProtein Usingan In Vitro Transcription-Translation System.
￿
Plasmid
pSP18 containing the 0.3-kb Pst I-Eco RI fragment coding for most of theMDNCF
protein (amino acid residues 17-96) was transcribed by SP6 RNA polymerase, fol-
lowed by translation of the in vitro-synthesized mRNA with a reticulocyte lysate
and immunoprecipitation of thetranslated protein by rabbit anti-MDNCF antibody.
As shown in Fig. 2, significant amounts of radiolabeled 10-kD MDNCF could be
precipitated by antibody, but not by normal rabbit serum . However, we could not
detect chernotactic activity using this cell-free translated material .
Amino Acid Sequence Homology With Other Cytokines.
￿
After establishing the entire
cDNA sequence, we found striking sequence similarity betweenMDNCF and human
platelet basic protein (PBP) (14)and PF4 (15) as well as v-src-inducible protein (9E3)
(16), IFN-y inducible protein (IP 10-y) (17), and a growth-regulated gene product
in transformed cells (gro) (18) as shown in Fig . 3. The positions of four cysteines
(at residues 34, 36, 61, and 77) are identical among these proteins . The greatest
similarity was observed between MDNCF and 9E3 (50 identities out of 98 amino
acid possible matches, and 59% in nucleotide matches of the coding region) . The
similarity in protein structure was also established by a hydrophobicity output test
between MDNCF and 9E3, as shown in Fig . 3 B.
Induction ofMDNCFmRNA in Human PBMC by LPS, IL-1, and TNF .
￿
TotalRNA
wasprepared from LPS-stimulated PBMC, and Northern blotting analysis was per-
formed . As shown in Fig . 4 a, LPS induced high levels of mRNA forMDNCF (1.8
kb) at 1 h, which reached a maximum at 3 h . The high level ofmRNA persisted1888
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FIGURE 4 .
￿
(a) Northern blotting analysis ofmRNA induction in LPS stimulated PBMC after
0 h (lane 1), 1 h (lane 2), 3 h (lane 3), 6 h (lane 4), 16 h (lane 5). Lane 6 represents themRNA
in PBMC cultured for 16 h without LPS . (b) Expression ofMDNCFmRNA in PBMC at 4 h
after stimulation with medium alone (lane 1), IL-1 (lane 2), IL-2 (lane 3), TNF(lane 4), IFN-y
(lane 5), and IFN-a (lane 6). (c) HPLC gel filtration analysis of LPS, IL-1 and TNFinduced
neutrophil chemotactic activity. 5 x 106 PBMC/ml in RPMI-1640 medium supplemented with
l o go FCS were cultured for 16 h in the presence of 10 jig/ml LPS, 100 U/ml IL-1, or 100 U/ml
TNF The culture supernatants were concentrated 20-fold byAmiconCorp. (Danvers,MA) diaflow
membranes(YM 5) and 250 ul ofeach sample was applied to HPLC gel filtration column . The
chemotactic activity was measured at 1 :4 dilution .
as long as 16h. Small amounts ofMDNCFmRNA were detected in nonstimulated
PBMC at the end of the culture period. This was not due to endotoxin contamina-
tion becausewe did not observe any induction of IL-1a or ßmRNA underthe same
culture conditions . The induction ofMDNCFmRNA preceded the appearance of
MDNCF activity in culture media(4) . We also tested cytokines, including IL-1, IL-1890
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2, TNF, IFN-a, and INFy that activate human monocytes for their capacity to in-
duce MDNCF mRNA.
As shown in Fig. 4 b, both II-1 and TNF induced similarly high levels of MDNCF
mRNA. The time course of MDNCF mRNA induction by IL-1 and TNF was similar
to that obtained with LPS (data not shown) . Neutrophil chemotactic activity was
detected in both IL-1- and TNFstimulated PBMC culture media. The activity was
eluted from HPLC gel filtration column in the same location as LPS-induced MDNCF
(Fig. 4 c).
Discussion
We have cloned the cDNA that encodes for human MDNCF. The deduced amino
acid sequence of the open reading frame was compared with the previously deter-
mined NH2-terminal amino acid sequence of purified MDNCF. This shows that
the NH2 terminal of mature MDNCF corresponds to serine at residue 28 of the
deduced amino acid sequence. We have recently chemically synthesized a polypep-
tide corresponding to this mature MDNCF polypeptide (residues 28 to 99), and
this product has potent neutrophil chemotactic activity (Appella, E., S. Tanaka,
K. Matsushima, and T. Yoshima, unpublished observation). The result confirms
that the cDNA encodes for MDNCF Experiments are in progress to express MDNCF
in mammalian cells and E. coh .
Recently, Schmidt and Weissmann (19) reported a cDNA sequence that is iden-
tical to that of MDNCF, except for minor differences. Our cDNA is 11 bases longer
at the 5' region and about 100 bases shorter at the 3' regions. In the 3' noncoding
region we identified the bases at positions 650 and 1258 as G and A, respectively,
in contrast to the published A and T. Schmidt and Weissmann obtained their cDNA
from mRNA that was increased 10-fold above control levels when human PBMC
were stimulated with staphylococcal enterotoxin, a potent lymphocyte mitogen. In
vitro translation of cDNA-derived mRNA in a reticulocyte lysate yielded a peptide
with a molecular mass of ti 11 kD, a value consistent with the length of the open
reading frame of the cDNA. Since this discovery was based on cDNA cloning, the
authors were unable to attribute a function to the peptide or to know the size of
the natural cellular product.
The striking similarity ofthe aminoacid sequence of MDNCF with several known
proteins that are believed to be involved in inflammation and cell growth, particu-
larly with a v-src-induced protein (9E3) sequence, suggests MDNCF may have other
as yet unidentified biological activities. 9E3 has been cloned by identifying the pre-
dominant mRNA induced after oncogenic transformation of chicken fibroblasts by
v-src. Although at present the function ofthis protein is unknown, this molecule may
function as an autocrine factor that promotes the growth of fibroblasts and is in-
volved in the neoplastic transformation offibroblasts by v-src (16). Therefore, we tested
whether v-src-transformed NIH 3T3 cells express a higher level ofmurine MDNCF
mRNA than that observed in normal NIH 3T3 cells. Although human MDNCF
cDNA probe detected ti2 kb mRNA in murine NIH 3T3 cells, we did not see any
increase in the level of this mRNA in v-src-transformed cells. We have also tested
whether or not tyrosine kinase activators induce MDNCF mRNA, because src pro-
tein is well known to have tyrosine kinase activity and to be closely associated withMATSUSHIMA ET AL.
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growth factor stimulation. We could not detect any induction of MDNCF mRNA
in human normal dermal fibroblasts by epidermal growth factor, whereas we ob-
served the rapid, dramatic induction of MDNCF mRNA in fibroblasts by IL-1 and
TNF (data not shown).
The induction ofMDNCFactivity by IL-1 and TNF in human PBMC and fibro-
blasts could account for the considerable in vivo neutrophil attractive capacity of
IL-1 despite lack of chemotactic activity in vitro. Since multiple steps are involved
in chemoattraction of neutrophils from the blood stream to inflammatory sites, such
as adhesion of neutrophils to the endothelial lining of blood vessels, infiltration of
neutrophils through the endothelial lining, and movement to the inflammatory site,
it is possible that multiple mediators are involved in these steps (20). It has been
reported that IL-1 and TNF increase the adhesion of neutrophils to endothelium
in vitro through the induction of adhesive molecules, and it is now clear that IL-1
and TNF induce MDNCF by PBMC and dermal fibroblasts (20). Therefore, IL-1
and TNF generate inflammatory infiltrates in vivo by inducing both adhesive and
chemotactic molecules.
The time course of the induction of MDNCF by LPS, IL-1, and TNF in vitro
is comparable to the time course of the in vivo accumulation of neutrophils at sites
of injected IL-1, TNF, or LPS (20). It has been reported that FMLP induces neu-
trophil accumulation at 30 min to 1 h, but IL-1 induces intradermal neutrophil ac-
cumulation at 1-3 h. Therefore, the time lag between FMLP that is directly
chemotactic and IL-1 may be due to the induction of MDNCF production by IL-1 .
This idea is supported by data showingthat theinductionofintradermalneutrophil
accumulation by IL-1 could be blocked by a protein synthesis inhibitor, cyclohexi-
mide (20).
The cloning of cDNA for MDNCF has provided the basis for both recombinant
and chemical synthesis of the molecule. This will enable us to make considerable
progress defining MDNCF sites of synthesis, receptors, and contribution to acute
and chronic inflammation.
Summary
The cDNA coding for human monocyte-derived neutrophil-specific chemotactic
factor (MDNCF) was cloned from LPS-stimulated human monocyte mRNA. The
cDNA sequence codes for a polypeptide consisting of 99 amino acids, including a
putative signal sequence. Comparison of the deduced amino acid sequence with the
NHZ-terminal amino acid sequence of natural MDNCF shows that the mature
functional protein comprises 72 amino acids, beginning with serine at residue 28.
The deduced amino acid sequence shows striking similarity to several platelet-derived
factors, a v-src-induced protein, a growth-regulated gene product (gro), and an IFN-y
inducible protein. The availability of the MDNCF cDNA enabled us to use it as
a probe to identify inducers of MDNCF mRNA expression in human PBMC.
MDNCF mRNA was increased >10-fold within 1 h after stimulation with LPS, IL-
1, or TNF, but not by IFN-y, IFN-a, or IL-2. Furthermore, we also determined
that LPS, IL-1, and TNF stimulated the mononuclear cells to produce biologically
active MDNCF This observation may account for the in vivo capacity of IL-1 and
TNF to induce netrophil infiltrates.1892
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